Thalidomide and irinotecan-associated diarrhea.
Tchekmedyian
N Simon
NS
D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D000368:Aged; D000369:Aged, 80 and over; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D002166:Camptothecin / Q000009:adverse effects* / Q000031:analogs & derivatives; D003967:Diarrhea / Q000139:chemically induced* / Q000517:prevention & control; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000077146:Irinotecan; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000473:pathology; D013792:Thalidomide / Q000627:therapeutic use*
D000972:Antineoplastic Agents, Phytogenic; D007166:Immunosuppressive Agents; D013792:Thalidomide; D000077146:Irinotecan; D002166:Camptothecin